Core H: Religious Orders Study Core
核心 H:宗教秩序研究核心
基本信息
- 批准号:10264500
- 负责人:
- 金额:$ 70.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAgingAlzheimer disease preventionAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAustraliaAutopsyBiologicalBiological MarkersBloodBrainBrain PathologyCell modelChicagoClinicalClinical DataCognitive agingCollaborationsCommunitiesCountryCountyDataData CollectionDementiaDiagnosisDiseaseDisease modelEnrollmentEnsureEtiologyEuropeFar EastFundingGoalsHealthHeterogeneityHumanImpaired cognitionInfrastructureLatinoLinkMagnetic Resonance ImagingManuscriptsMemoryMethodsMiddle EastMinorityMolecular ProfilingNatureNormalcyNorth AmericaOnline SystemsPaperPathogenesisPeer ReviewPersonsPopulation StudyPrecision HealthProcessRecommendationReligion and SpiritualityReportingResearchResearch PersonnelResearch Project GrantsResource SharingResourcesRisk FactorsSisterSouth AmericaSpecimenStrategic PlanningStructureSystems BiologyTimeWomanWorkdata managementdata sharingdesignfollow-uphealth disparityhuman dataimprovedin vivoinnovationmenmotor impairmentmultidisciplinaryneuroimagingneuropathologyopen dataoperationoutreachprecision medicinepredictive modelingpublic-private partnershiprecruitreligious order studyresearch clinical testingresearch studytoolvirtual
项目摘要
ABSTRACT – RELIGIOUS ORDERS STUDY CORE
The overall goal of the Religious Orders Study (ROS) Core is to support high quality, cutting edge, research
projects on the etiology, pathogenesis, diagnosis, treatment, and prevention of Alzheimer’s disease and related
dementias (AD/ADRD). The ROS Core will support a wide range of research studies that address several
NAPA milesstones, including, 1) Population Studies; 2) Precision Medicine & Health Disparities; and 3)
Disease Mechanisms, and Biomarkers & Diagnosis. The ROS Core, will 1) recruit, enroll, older Catholic
religious men and women, who agree to annual clinical evaluations, blood draw and brain donation; 2) support
studies: a) of the transition from no cognitive impairment (NCI) to MCI to the earliest stages of dementia; b)
linking risk factors to normality, incident MCI, and incident AD/ADRD; c) of the progression and consequences
of impaired motor function; and 3) facilitate externally funded research that aligns with the recommendations of
the 2017 NIA strategic plan, including studies that: a) recognize the heterogeneity and multifactorial nature of
dementias; b) support extensive molecular profiling to fill the gaps in large-scale human data needed to build
predictive models of disease and wellness; c) employ new research paradigms such as systems biology and
innovative human cell modeling; d) enable rapid and extensive sharing of data, disease models, specimens,
and support open science; e) build multidisciplinary translational teams in virtual and real spaces for these
teams to operate; and f) develop new precompetitive public-private partnerships.
The ROS Core has been in operation since 1994. It supports studies a) of the heteogenety of cognitive aging
and mixed brain pathologies, b) of exensive molecular profiling, c) that employ systems biology and human cell
modeling, d) whose data are rapidly disseminated via the RADC Hub, AMP-AD, and NIAGADS, e) that employ
multi- and inter-disciplinary teams across the country and across the globe, and f) that work in public-private
partnerships in the precompetitive space with AMD-AD and its sister studies. Excluding consortium papers, it
has resulted in more than 650 peer-reviewed manuscripts that have been highly impactful on the field with 4
papers having 1000-1499 citations, 3 with 700-999, and 7 with 500-699. The top 10 papers were cited an
average of 922 times. Further, ROS Core data and biospecimens have been shared with investigators at
nearly all other NIA-funded AD Centers, across the county and north America, south America, Europe, the
middle east, Asia and Australia as further evidence of the value of the resource (see Overall Tables 1-6 and
Resource Sharing Plan). The ROS Core set the standard for harmonization with the Clinical and Latino Cores,
affiliated studies Rush Memory and Aging Project and the Minority Aging Research Study, and with the
Chicago Health and Aging Proect.
摘要-教团研究的核心
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID ALAN BENNETT其他文献
DAVID ALAN BENNETT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID ALAN BENNETT', 18)}}的其他基金
Whole Genome Sequencing and Admixture Analyses of Neuropathologic Traits in Diverse Cohorts in USA and Brazil
美国和巴西不同群体神经病理特征的全基因组测序和混合分析
- 批准号:
10590405 - 财政年份:2023
- 资助金额:
$ 70.65万 - 项目类别:
Use and Impact of Novel and Repurposed Therapeutics for Alzheimer's Disease and Related Dementia in Diverse Populations
新型和改造疗法在不同人群中治疗阿尔茨海默病和相关痴呆症的使用和影响
- 批准号:
10655203 - 财政年份:2023
- 资助金额:
$ 70.65万 - 项目类别:
Genome-wide mapping and integrative analysis of DNA 6mA methylome in human AD brain
人类 AD 大脑 DNA 6mA 甲基化组的全基因组作图和综合分析
- 批准号:
10172823 - 财政年份:2019
- 资助金额:
$ 70.65万 - 项目类别:
Genome-wide mapping and integrative analysis of DNA 6mA methylome in human AD brain
人类 AD 大脑 DNA 6mA 甲基化组的全基因组作图和综合分析
- 批准号:
10404653 - 财政年份:2019
- 资助金额:
$ 70.65万 - 项目类别:
相似海外基金
Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
- 批准号:
24K18114 - 财政年份:2024
- 资助金额:
$ 70.65万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
- 批准号:
10089306 - 财政年份:2024
- 资助金额:
$ 70.65万 - 项目类别:
Collaborative R&D
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
- 批准号:
498288 - 财政年份:2024
- 资助金额:
$ 70.65万 - 项目类别:
Operating Grants
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
- 批准号:
498310 - 财政年份:2024
- 资助金额:
$ 70.65万 - 项目类别:
Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
- 批准号:
23K20339 - 财政年份:2024
- 资助金额:
$ 70.65万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
- 批准号:
2740736 - 财政年份:2024
- 资助金额:
$ 70.65万 - 项目类别:
Studentship
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
- 批准号:
2305890 - 财政年份:2024
- 资助金额:
$ 70.65万 - 项目类别:
Fellowship Award
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
- 批准号:
2406592 - 财政年份:2024
- 资助金额:
$ 70.65万 - 项目类别:
Standard Grant
McGill-MOBILHUB: Mobilization Hub for Knowledge, Education, and Artificial Intelligence/Deep Learning on Brain Health and Cognitive Impairment in Aging.
McGill-MOBILHUB:脑健康和衰老认知障碍的知识、教育和人工智能/深度学习动员中心。
- 批准号:
498278 - 财政年份:2024
- 资助金额:
$ 70.65万 - 项目类别:
Operating Grants
Welfare Enhancing Fiscal and Monetary Policies for Aging Societies
促进老龄化社会福利的财政和货币政策
- 批准号:
24K04938 - 财政年份:2024
- 资助金额:
$ 70.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




